Rao SN, Raviv T, Majmudar PA, Epstein RJ. Role of Orbscan II in Screening Keratoconus Patients before Refractive Surgery, Ophthalmol 2002; 109:1642-1646.
Lane HA, Swale J, Majmudar PA. Prophylactic Use of Mitomycin-C in the Management of Buttonholed LASIK Flaps. J Cataract Refract Surg 2003 February, 29:390-392.
Muller LT, Candal EM, Epstein RJ, Dennis RF, Majmudar PA. Transepithelial phototherapeutic keratectomy/photorefractive keratectomy (PTK/PRK) with Adjunctive Mitomycin-C for Complicated LASIK Flaps, Journal of Cataract and Refractive Surgery, February 2005; 31(2), 209-216.
Majmudar PA, “The Role of Mitomycin-C in Corneal Refractive Surgery”, Techniques in Ophthalmology. Vol. 2, No. 2, June 2004, 43-9.
Klein SR, Epstein RJ, Majmudar PA, Muller LT. Management of Complicated or Buttonhole LASIK Flaps With Transepithelial Phototherapeutic Keratectomy/Photorefractive Keratectomy With Adjunctive Mitomycin C. Techniques in Ophthalmology, September 2004, Volume 2, Issue 3, p. 110-113.
Spanggord HM, Epstein RJ, Lane HA, Candal EM, Klein SR, Majmudar PA, Dennis RF, “Flap suturing with proparacaine for recurrent epithelial ingrowth following laser in situ keratomileusis surgery,” Journal of Cataract and Refractive Surgery, 2005; 31(5); May 2005, p. 916-921.
Lacayo GO, Majmudar PA. How and when to use Mitomycin-C in refractive surgery, Curr Opin Ophthalmol, 2005, 16(4):256-259.
Majmudar PA, Epstein RJ, Parent A, et al. Non-Invasive Diagnosis Of Epithelial Downgrowth Following Penetrating Keratoplasty Using Immunohistochemical Analysis Of Resected Corneal Buttons, Cornea, 2006 Jul;25(6):727-33.
Majmudar PA, Clinch T, Comstock, T et al. Prospective evaluation of the safety of besifloxacin ophthalmic suspension 0.6% in cataract and refractive surgery, Cornea May 2014, 33(5), 457-62.
Masket S, Hovanesian JA, Levenson J, Tyson F, Flynn W, Endl, M, Majmudar PAet al. Randomized comparison of a hydrogel sealant versus sutures for prevention of fluid egress following cataract surgery, J Cataract Refract Surg (Dec.) 2014; 40:2057-2066.
Walters T, Endl M, Elmer TR, Levenson J, Majmudar PA, Masket S. Dexamethasone Punctum Plug for the Treatment of Ocular Inflammation and Pain after Cataract Surgery, J Cataract Refract Surg 2015 Oct;41(10):2049-59. doi: 10.1016/j.jcrs.2015.11.005.
Majmudar PA, et al. Mitomycin C in Surface Ablation: Ophthalmic Technology Assessment, Ophthalmology June 2015 122(6):1085-95.
Donnenfeld ED, Karpecki PM, Majmudar PAet al. Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients 1 With Dry Eye Disease: A 1 Year, Multicenter, Randomized, Placebo-Controlled Study, Cornea, 2016 Jun; 35(6): 741–748.
Majmudar PA, Johnson L. Enhancing DMEK Success by Identifying Optimal Levels of Trypan Blue Dye Application to Donor Corneal Tissue, Cornea, Feb 2017 36(2). 217-21.
Milner MS, Beckman K, Luchs J, Majmudar PA et al, Dysfunctional tear syndrome: dry eye disease and associated tear film disorders – new strategies for diagnosis and treatment. Current Opinion in Ophthalmology, vol 27, 2017.
Trattler WB, Majmudar PA, Donnenfeld ED, et al. The Prospective Health Assessment of Cataract Patients’ Ocular Surface (PHACO) Study: the effect of dry eye, ClinicalOphthalmology, 2017:11, 1-8.
Torkildsen G, Brujic M, Cooper MS, Karpecki P, Majmudar PA et al. Evaluation of a new artificial tear formulation for the management of tear film stability and visual function in patients with dry eye, ClinicalOphthalmology 2017:11 1883–1889.
Rubinfeld RS, Epstein RH, Majmudar PA, et al. Transepithelial crosslinking retreatment of progressive corneal ectasia unresponsive to classic crosslinking. J Cataract Refract Surg. 2017;43(1):131-135.
Nichols KK, Holland E, Toyos M, Peace JH, Majmudar PAet al. Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial, Clin Ophthalmol. 2018 Jan 31;12:263-270. doi: 10.2147/OPTH.S152841. eCollection 2018. Erratum in: Clin Ophthalmol. 2018 May 17;12:913.
Tu EY, Majmudar PA. Adjuvant Stromal Amphotericin B Injection for Late-Onset DMEK Infection. Cornea 2017;36(12):1556-8.
Thompson JM, Truong AH, Stern HD, Djalilian A, Cortina MS, Tu EY, Johnson P, Verdier DD, Rafol L, Lubeck D, Spektor T, Jorgensen C, Rubenstein JB, Majmudar PA, Talati R, Basti S, Feder R, Sugar A, Mian SI, Balasubramanian N, Sandhu J, Gaynes BI, Bouchard CS. A Multicenter Study Evaluating the Risk Factors and Outcomes of Repeat Descemet Stripping Endothelial Keratoplasty. Cornea. 2019 Feb;38(2):177-182.
Tauber J, Wirta DL, Sall K, Majmudar PA, Willen D, Krösser S. A Clinical Phase 2 Study (SEECASE-1) to Assess Efficacy, Safety and Tolerability of NOV03 for Treatment of Signs and Symptoms of Dry Eye Disease, submitted for publication, 2020.
Beckman K, Katz J, Majmudar PA, et al. Loteprednol Etabonate for the Treatment of Dry Eye Disease: A Systematic Review, Journal of Ocular Pharmacology and Therapeutics, Accepted for publication April 6, 2020.
Accessibility: If you are vision-impaired or have some other impairment covered by the Americans with Disabilities Act or a similar law, and you wish to discuss potential accommodations related to using this website, please contact our Accessibility Manager at (800) 8-CORNEA.